sugammadex sandoz 100 mg/ml sol. inj. i.v. flac.
sandoz sa-nv - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex sandoz 100 mg/ml sol. inj. i.v. flac.
sandoz sa-nv - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex reddy 100 mg/ml sol. inj. i.v. flac.
reddy holding gmbh - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex teva 100 mg/ml sol. inj. i.v. flac.
teva b.v. - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex teva 100 mg/ml sol. inj. i.v. flac.
teva b.v. - sugammadex sodique 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution injectable - 100 mg/ml - sugammadex sodique 108.8 mg/ml - sugammadex
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - blocus neuromusculaire - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
gla 130 primrose oil capsule
seroyal international inc. - acide gamma-linolénique; acide linoléique; acide oléique - capsule - 130mg; 900mg; 100mg - acide gamma-linolénique 130mg; acide linoléique 900mg; acide oléique 100mg - other nutritional agents
borage oil capsules
general nutrition canada inc. - acide linoléique; acide gamma-linolénique; acide oléique; acide palmitique - capsule - 375mg; 258mg; 148mg; 96mg - acide linoléique 375mg; acide gamma-linolénique 258mg; acide oléique 148mg; acide palmitique 96mg - herbs and natural products
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocus neuromusculaire - tous les autres produits thérapeutiques - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocus neuromusculaire - tous les autres produits thérapeutiques - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.